Acutaas Chemicals Limited
Bombay Stock ExchangeTotal Valuation
Acutaas Chemicals Limited carries a market capitalization of 287.72B, placing it among publicly traded companies globally. Its enterprise value stands at 139.42B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 287.72B |
| Enterprise Value | 139.42B |
Valuation Ratios
Acutaas Chemicals Limited trades at a trailing price-to-earnings ratio of 64.93.
| PE Ratio | 64.93 |
| PS Ratio | 15.46 |
| PB Ratio | N/A |
| P/TBV Ratio | N/A |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
Enterprise Valuation
On an enterprise value basis, Acutaas Chemicals Limited trades at an EV/EBITDA multiple of 53.36 and an EV/FCF ratio of 8,891.17. The EV/Sales ratio of 15.46 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 53.36 provides insight into valuation relative to core operating earnings.
| EV / Sales | 15.46 |
| EV / EBITDA | 53.36 |
| EV / EBIT | 53.36 |
| EV / FCF | 8,891.17 |
Financial Position
Acutaas Chemicals Limited maintains a current ratio of 3.91, meaning it holds 3.9x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 0.98, indicating moderate leverage, while an interest coverage ratio of 124.24 demonstrates strong ability to service its debt obligations.
| Current Ratio | 3.91 |
| Quick Ratio | 1.23 |
| Debt / Equity | 0.98 |
| Debt / EBITDA | N/A |
| Interest Coverage | 124.24 |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | N/A |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | 29.58 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Taxes
Over the trailing twelve months, Acutaas Chemicals Limited has paid 726.33M in income taxes, reflecting an effective tax rate of 25.43.
| Income Tax | 726.33M |
| Effective Tax Rate | 25.43 |
Stock Price Statistics
Acutaas Chemicals Limited's stock has gained approximately 211.28925% over the past 52 weeks. The 50-day moving average sits at 3,018.86, while the 200-day moving average is 2,157.03.
| Beta (5Y) | N/A |
| 52-Week Price Change | 211.28925% |
| 50-Day Moving Average | 3,018.86 |
| 200-Day Moving Average | 2,157.03 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Acutaas Chemicals Limited generated 9.02B in revenue and converted that into 2.15B in net income, yielding earnings per share of 25.92. EBITDA reached 2.61B, while operating income came in at 2.61B.
| Revenue | 9.02B |
| Gross Profit | 4.32B |
| Operating Income | 2.61B |
| Pretax Income | 2.86B |
| Net Income | 2.15B |
| EBITDA | 2.61B |
| EBIT | 2.61B |
| Earnings Per Share (EPS) | 25.92 |
Margins
Acutaas Chemicals Limited operates with a gross margin of 47.88, reflecting its pricing power and cost economics. The operating margin of 28.97 and net profit margin of 23.81 provide insight into operational efficiency.
| Gross Margin | 47.88 |
| Operating Margin | 28.97 |
| Pretax Margin | 31.66 |
| Profit Margin | 23.81 |
| EBITDA Margin | 28.97 |
Stock Splits
Acutaas Chemicals Limited's most recent stock split took place on April 25, 2025 with a 1:2 split ratio.
| Last Split Date | 4/25/2025 |
| Split Ratio | 1:2 |
Scores
Acutaas Chemicals Limited posts an Altman Z-Score of 2.03, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 2.03 |